Update on the prevention and treatment of endophthalmitis
- PMID: 26609317
- PMCID: PMC4655603
- DOI: 10.1586/17469899.2014.951331
Update on the prevention and treatment of endophthalmitis
Abstract
Endophthalmitis remains a rare but serious cause of visual loss. Over time, changes have been noted in endophthalmitis in terms of predominant causes, infecting organisms, and antibiotic susceptibilities. There is controversy regarding the use of intracameral prophylactic antimicrobials during cataract surgery. Alternatively, there appears to be increasing evidence against using routine topical antibiotics for intravitreal injections. There are also increasing reports of multidrug-resistant organisms causing endophthalmitis, but the combination of vancomycin and ceftazidime appears effective for the vast majority of cases. Future trends may involve increasing utilization of polymerase chain reaction for diagnosis, and possibly office-based pars plana vitrectomy for treatment of endophthalmitis.
Keywords: Antibiotics; Endophthalmitis; Intravitreal injection; Pars plana vitrectomy; Polymerase chain reaction.
Conflict of interest statement
The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Figures
References
-
- Schwartz SG, Flynn HW, Jr, Scott IU. Endophthalmitis: classification and current management. Expert Rev. Ophthalmol. 2007;2(3):385–396.
-
- Park JC, Ramasamy B, Shaw S, Ling RH, Prasad S. A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: clinical presentation, microbiology, management and outcome. Br. J. Ophthalmol. 2014 Mar 31; [Epub ahead of print] - PubMed
-
- Govetto A, Virgili G, Menchini F, Lanzetta P, Menchini U. A systematic review of endophthalmitis after microincisional versus 20-gauge vitrectomy. Ophthalmology. 2013;120(11):2286–2291. - PubMed
-
- Kessner R, Golan S, Barak A. Changes in the etiology of endophthalmitis from 2003 to 2010 in a large tertiary medical center. Eur. J. Ophthalmol. 2014 May 1; [Epub ahead of print] - PubMed
-
- Matthews JL, Dubovy SR, Goldberg RA, Flynn HW., Jr Histopathology of Streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients. Ophthalmology. 2014;121(3):702–708. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous